Cutting a hole in the heart to treat congestive heart failure may sound counterintuitive, but a Texas Medical Center (TMC) startup company hopes to do just that.
Alleviant Medical is developing a transcatheter device to treat diastolic heart failure, which occurs when one or both of the ventricles do not fill up properly with blood and are unable to pump enough blood to the rest of the body.
The device will enter the body near the groin, travel through the body via the femoral vein, and then gain access to the heart. At that point, an expandable blade will cut a hole in the wall separating the left and right atria. The blade and tissue will be pulled back into the device, which will then be removed.
This hole will help blood flow from the left chamber to the right chamber of the heart.
Over the past 20 years or so, medical devices, treatments and drugs have helped people with heart disease, but there are few options for people suffering from heart failure, said Jacob Kriegel, M.D., co-founder and CEO of Alleviant Medical.
“It’s a very morbid condition, so it rose to the top of the list as an important unmet need,” Kriegel said.
Kriegel and his colleagues, Alex Arevalos, Ph.D., Albertien Greijdanus, MSc, and Avni Patel, M.E., examined several hundred unmet needs as part of TMC Biodesign, a one-year fellowship program that gathers people with diverse backgrounds to solve health care problems via medical devices or digital products.
“As a cardiac surgery trainee, I had seen hundreds of heart failure patients, but for me, it took sitting down with engineers to see the problem through new eyes,” Kriegel said. “Our perspectives merged with market opportunity.”
Kriegel and his colleagues understand that creating a hole in the heart comes with risk. But if the hole is precisely sized, it can distribute the correct amount of pressure from the left atrial to the right atrial without dramatically increasing the right-sided pressure—a therapeutic benefit while minimizing risk. The hole will allow blood to flow naturally from the left chamber to the right chamber, lowering the pressure on the left and slightly increasing the pressure on the right, where it is already low, Kriegel said.
With every heartbeat, it is expected that 30 percent of the blood in the left atrium will transfer into the right atrium, and the remaining 70 percent will get pumped forward along its natural pathway into the left ventricle and out to the body, he added. The blood that gets sent into the right atrium will travel to the lungs and then continue along through the normal circulation.
A hole may drastically improve quality of life for older patients, keeping them independent and out of the hospital.
“The hole we create will be the least of their problems, and we believe it will alleviate their symptoms,” Kriegel said.
Current treatments for heart failure include a diuretic, or water pill, but that medication has side effects that include kidney failure. Other treatment options include inserting a stent—an expandable mesh tube, usually made of stainless steel—to create a passageway between the left and right atria that allows blood to flow more freely. But all implantable devices come with the risk of blood clots—which can grow around the device—and stroke.
Alleviant Medical’s device packs the severed tissue down inside the device and removes it safely from the body. That’s important, because any particle or foreign material left can flow into the brain and cause a stroke, Kriegel said.
Though the company is less than a year old, it has gained traction in the business plan competition circuit. Already, Alleviant Medical has won challenges at Rice University and the University of Massachusetts. The team plans to continue at the Texas Medical Center, joining the upcoming TMCx medical device accelerator.
“These competitions have been good learning experiences for us because we have received validation on our device,” Kriegel said. “We’ve been able to see where our risks are, where we have proven the technology and what people are concerned about. Overall, we hear good things, and that people are looking for a new solution to the problem.”
@bigdock Great news! Sending you our best wishes.
If you love citrus, you will really love these recipes with options from salad to stir-fry.
Women with darker skin can get #skincancer, too. Our Dr. Susan Chon shares what you should know: https://t.co/02BBg4YNmw @thirdAGE #endcancer
Overcoming #cancer shapes 3 MD Anderson employees’ perspectives: https://t.co/cUt1DJj9F1 #endcancer https://t.co/FmZgRjUw0b
University of Houston@UHouston
Legacy is planting seeds in a garden you never get to see. Tonight we’re celebrating the legacy of @UHValentiSchool. Thank you @seguntheprogram for being MC and @jdbalart for the Impact Award https://t.co/tBmWEylyiU
Entering a new era: learn more about TMC3, the new translational research campus. https://t.co/pCLaez3zts
Be a part of the nation's largest autism research study. Get in-person help with signing up for SPARK for Autism at the Houston Museum of Natural Science during their sensory friendly event April 28. http://bit.ly/SPARKevents
An Army Veteran confronts his own trauma with a camera https://t.co/qoMYFKKZjq via @nytimes
In this interview with @ktrhnews, Dr. James Langabeer of @UTHealth_SBMI and @UTEmergencyMed discusses the decline in prescriptions for addictive painkillers: https://t.co/CMlYcJngA4
At 10 months old, David was so weak and behind in development that he couldn't even sit up. But now the bubbly 4-year-old is growing fast and swinging baseball bats. Read about his miraculous journey w/@UTPhysicians CARE Clinic. https://t.co/3chQLYaeex #ManyFacesOfUTHealth https://t.co/LZptSVgsDY
RT @UTCVSurgery: Another great free medical screening service brought to you by @UTPhysicians! Check out Dr Stuart Harlin on this morning’s…
Veterans serving Veterans: Researchers who served. This @usairforce Veteran volunteered as a pararescueman in Vietnam, and then went on to serve others with a career in orthopedic research. https://t.co/2NQHhSTmQx via @VeteransHealth on #VAntagePoint
At 10 months old, David was so weak and behind in development that he couldn't even sit up. But now the bubbly 4-year-old is growing fast and already swinging baseball bats. Read about his miraculous journey with the UT Physicians CARE Clinic. #ManyFacesOfUTHealth
Today’s #VeteranOfTheDay is Navy Veteran Willard Knockum Jr. Willard served from 1964 to 1971 during the Vietnam War. Willard joined the Navy in 1964. He was trained in counterinsurgency and survival surveillance reconnaissance and weapons at the Marine Base Camp in Pendleton, California. He became a Boatswain Mate, a role that fulfills a variety of tasks such as lookout duty, training and directing maintenance duties, damage control, operating and maintaining equipment and more. Willard also participated in North Atlantic Treaty Organization and anti-submarine warfare exercises. Willard served on the destroyer USS Fox 779 before he deployed to Vietnam in 1969 during the Vietnam War where he served in Saigon and Dong Tam. He was assigned to Military Assistance Command, a group of assault river boats that patrolled hostile waters around the Army Base at Dong Tam. For his service, Willard was awarded the Vietnam Service Medal and the Republic of Vietnam Campaign Medal. Willard now lives in Folsom, Louisiana as a retired United Postal Service mail handler. Thank you for your service, Willard!
Today’s #VeteranOfTheDay is @USNavy Veteran Willard Knockum, Jr https://t.co/7lDPTdSI86